Literature DB >> 18395834

Use of ERT2-iCre-ERT2 for conditional transgenesis.

Nicolas Jullien, Isabelle Goddard, Samia Selmi-Ruby, Jean-Luc Fina, Harold Cremer, Jean-Paul Herman.   

Abstract

We examined the use of ERT2-iCre-ERT2 (Cre2ERT2), a tamoxifen-regulated form of Cre that has been described to have a background activity lower than that of other tamoxifen-regulated Cre constructs, for establishing performant conditional deleter mouse lines. Cre2ERT2 was inserted by homologous recombination into the Rosa26 locus. These mice were mated with R26R Cre-reporter mice. No recombination could be observed in the progenies in the absence of tamoxifen treatment. Tamoxifen treatment at E13-14 led to a high level, albeit variable, recombination in most of the tissues examined: liver, heart, kidney, brain, lung etc. Treatment of adult animals also induced recombination in these tissues, although at a lower level. Northern blot and qPCR studies suggested that these differences are not linked to significant variations of the level of expression of Cre2ERT2. Thus, Cre2ERT2 appears to be a good alternative to existing modulatable Cre systems, displaying a lack of background activity and a high-level inducibility in vivo. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395834     DOI: 10.1002/dvg.20383

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  7 in total

1.  Neurogenin 2 regulates progenitor cell-cycle progression and Purkinje cell dendritogenesis in cerebellar development.

Authors:  Marta Florio; Ketty Leto; Luca Muzio; Andrea Tinterri; Aurora Badaloni; Laura Croci; Paola Zordan; Valeria Barili; Ilaria Albieri; François Guillemot; Ferdinando Rossi; G Giacomo Consalez
Journal:  Development       Date:  2012-07       Impact factor: 6.868

2.  Tissue-Specific Regulation of Oncogene Expression Using Cre-Inducible ROSA26 Knock-In Transgenic Mice.

Authors:  Brandi L Carofino; Monica J Justice
Journal:  Curr Protoc Mouse Biol       Date:  2015-06-01

3.  Tetracycline-controlled transgene activation using the ROSA26-iM2-GFP knock-in mouse strain permits GFP monitoring of DOX-regulated transgene-expression.

Authors:  Simone Wörtge; Leonid Eshkind; Nina Cabezas-Wallscheid; Bernard Lakaye; Jinhyun Kim; Rosario Heck; Yasmin Abassi; Mustafa Diken; Rolf Sprengel; Ernesto Bockamp
Journal:  BMC Dev Biol       Date:  2010-09-03       Impact factor: 1.978

4.  Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.

Authors:  Kristin B Andersson; Lisbeth H Winer; Halvor K Mørk; Jeffery D Molkentin; Frédéric Jaisser
Journal:  Transgenic Res       Date:  2009-11-06       Impact factor: 2.788

5.  Strict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells.

Authors:  U Sandhu; M Cebula; S Behme; P Riemer; C Wodarczyk; D Metzger; J Reimann; R Schirmbeck; H Hauser; D Wirth
Journal:  Nucleic Acids Res       Date:  2010-10-08       Impact factor: 16.971

6.  Survival of mature T cells in the periphery is intrinsically dependent on GIMAP1 in mice.

Authors:  Preeta Datta; Louise M C Webb; Inxhina Avdo; John Pascall; Geoffrey W Butcher
Journal:  Eur J Immunol       Date:  2016-11-25       Impact factor: 5.532

7.  GIMAP1 Is Essential for the Survival of Naive and Activated B Cells In Vivo.

Authors:  Louise M C Webb; Preeta Datta; Sarah E Bell; Daisuke Kitamura; Martin Turner; Geoffrey W Butcher
Journal:  J Immunol       Date:  2015-11-30       Impact factor: 5.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.